Oxymetazoline CAS: 1491-59-4

CAS NO: 1491-59-4
Oxymetazoline
Chemical Name: Oxymetazoline
Molecular Formula: C16H24N2O
Formula Weight: 260.37
CAS No.: 1491-59-4
Description Review
Description

Oxymetazoline is a topical decongestant that belongs to the class of phenylephrine derivatives. It works by narrowing blood vessels in the nasal passages, thereby reducing the swelling and congestion that commonly occur with hay fever, common cold, and chronic rhinitis. It is an FDA-approved drug that can be obtained as a generic drug, and it is available under multiple brand names such as Afrin, Neo-Synephrine, and Vicks Sinex.

Chemical name:

The chemical name of Oxymetazoline is 6-tert-butyl-3-(2-imidazolin-2-ylmethylaminomethyl) phenol.

Molecular formula:

The molecular formula of Oxymetazoline is C16H24N2O.

Formula weight:

The formula weight of Oxymetazoline is 260.4 g/mol.

CAS No:

The CAS number or chemical abstracts service number of Oxymetazoline is 1491-59-4.

Top ten keywords from Google and synonyms:

  1. Decongestant nasal spray
  2. Afrin nasal spray
  3. Oxymetazoline hydrochloride
  4. Blocked nose relief
  5. Nasal congestion relief
  6. Sinusitis relief
  7. Common cold remedy
  8. Phenylephrine derivative
  9. OTC nasal spray
  10. Vicks Sinex nasal spray

Health benefits:

Oxymetazoline is an effective remedy for relieving nasal congestion and swelling of the nasal passages, a common symptom of allergies, cold, flu, and sinusitis. It works quickly and effectively, with a full effect in as little as a few minutes, to ease breathing and provide relief from congestion for up to twelve hours.

Potential effects:

Oxymetazoline causes constriction of the blood vessels, leading to a reduction in the inflammation and congestion of the nasal passages. The active ingredient in this drug, oxymetazoline hydrochloride, acts through direct stimulation of the alpha-adrenergic receptors in the blood vessels, leading to constriction and a decrease in blood flow to the nasal mucosa. Its vasoconstrictive properties provide rapid relief from the symptoms of nasal congestion, including a runny or stuffy nose.

Product mechanism:

Oxymetazoline belongs to the class of alpha-adrenergic agonist drugs, which act on alpha receptors in the blood vessels to induce a narrowing or constriction of the blood vessels. When applied topically to the nasal passages, oxymetazoline binds to the alpha-adrenergic receptors and causes the blood vessels to constrict, reducing the amount of blood flow and reducing the inflammation and congestion of the nasal mucosa.

Safety:

Oxymetazoline is a generally safe drug when used according to the instructions. It is an FDA-approved drug that has been used safely for many years as a decongestant to relieve nasal congestion, particularly during a common cold. However, it is important to stick to the recommended dosage and avoid using it for more than 3-5 days at a time, as prolonged use can result in a condition known as rebound congestion, where the congestive symptoms return as soon as the medication is stopped. Additionally, the use of this drug should be avoided by people with high blood pressure,

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us